Wollenhaupt J, Silverfield J, Bong Lee E, et al. Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 9 Years. ACR 2017, abstract 522.
CD19 CAR T-celtherapie lijkt effectief bij auto-immuunziekten
jun 2024 | Sclerodermie, SLE